Octant Bio's synthetic biology approach to drug discovery is making progress, and the preclinical biotech has raised $80 million in Series B financing to continue the journey. The company added Bristol Myers Squibb as an investor and collaborator in the search for new immunology drugs.
MedCity INVEST PharmaTech 2022 is a virtual executive summit where established biopharma companies gather with health tech and digital health innovators to transform the industry.
Hospitals needs to make changes not only to retain clinicians but to stem financial losses. Healthcare leaders are committed to rising to the challenge, and investing in new processes and technologies to alleviate administrative pressures is a key way they're leading the charge.
AstraZeneca's Covid-19 antibody drug Evusheld reduced the risk of infection by 83% after six months. These results published in the New England Journal of Medicine are the latest clinical data supporting the durability of Evusheld, which was designed to offer longer-lasting protection.
By Arundhati Parmar Thursday, April 21, 2022 1:42 PM
In our conversation, Adrienne McFadden, who at one time was a practicing physician, speaks about the evolution of the company to more of a curated matchmaker connecting and guiding people to the best care available.
By Michael Schroeder Thursday, April 21, 2022 1:05 PM
Wallaby, which has its main offices in Laguna Hills, California and Shanghai, China, and Bochum, Germany-based phenox have been strategic partners since 2019. The deal is valued at about 500 million euros, including milestone payments, or the equivalent of more than $542 million.
A study from the New England Journal of Medicine found that AI coupled with Butterfly iQ, a handheld ultrasound device, can assess fetal gestational age as accurately as a trained sonographer with expensive, bulky equipment; the findings have implications for democratizing obstetric ultrasounds.
No comments